The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Hetero Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
63 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LAMAVIR 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABADINE 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LAMAVIR 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BORTEZOMIB HETERO bortezomib 3.5 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BORTEZOMIB GxP bortezomib 3.5 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BORTEZOMIB GPPL bortezomib 3.5 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BORTEZOTERO bortezomib 3.5 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FENOFIBRATE HT fenofibrate 145 mg film-coated tablet blister pack.